Clinical Cardiology Alert – October 1, 2008
October 1, 2008
View Issues
-
PCI and Quality of Life
This second publication from the COURAGE investigators reports on multiple assessments of quality of life, particularly angina presence and severity, between the two groups over the study observation. -
Sirolimus-Eluting Stents Superior to Paclitaxel-Eluting Stents in Diabetics
Diabetic patients are at higher risk for in-stent restenosis and stent thrombosis than their non-diabetic counterparts. -
Is Warfarin Bridging Therapy Always Necessary?
The management of anticoagulation in patients requiring long-term warfarin therapy is often problematic when they need cardiac catheterization. -
The Value of Apo B Measurements
In patients with elevated triglycerides, other atherogenic particles may be as important as LDL-cholesterol (C). These particles and LDL-C are measured as non-HDL-C, and are considered a secondary target of therapy. -
Physical Activity and the Risk of Atrial Fibrillation
The relationship between physical activity and atrial fibrillation has been controversial. Lone atrial fibrillation is relatively common in young, competitive athletes, and it is uncertain whether routine physical activity is protective or harmful in elderly populations where atrial fibrillation is more common. -
Current Value of Defibrillation Threshold Testing
The sudden cardiac death in heart failure trial (SCD-HeFT) was a study involving patients with ischemic and non-ischemic cardiomyopathy and a left ventricular ejection fraction < 35% and class II or III heart failure that tested the value of ICD therapy for the primary prevention of sudden cardiac death. -
Pharmacology Watch
Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news. -
Clinical Briefs in Primary Care supplement